In vitro studies using luminal breast cancer cells were performed to investigate the effects of siRNA knockdown of glutaminase genes (<i>GLS</i> and <i>GLS2</i>) and inhibition using CB-839 on functional assays. The gene discussed is GLS2; the disease is breast cancer.